凹室 发表于 2025-3-28 18:00:52

Introduction,ch by several laboratories to develop receptor subtype-specific NMDA antagonists in order to avoid the wide range of side-effects seen with non-selective NMDA ion channel antagonists such as ketamine.
页: 1 2 3 4 [5]
查看完整版本: Titlebook: Regulation Under Increasing Competition; Michael A. Crew Book 1999 Springer Science+Business Media New York 1999 Change.Monopol.competitio